University of Bordeaux Reports Findings in Heart Attack (One-year care pathway after acute myocardial infarction in 2018: Prescription, medical care and medication adherence, using a French health insurance reimbursement database): Heart Disorders and Diseases – Heart Attack

2022 FEB 11 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- New research on Heart Disorders and Diseases - Heart Attack is the subject of a report. According to news originating from Pessac, France, by NewsRx correspondents, research stated, “Myocardial infarction is a major cause of morbidity and mortality. Guidelines have been published to optimize medical care and involve optimization of the care pathway and hospital-city coordination.”

Our news journalists obtained a quote from the research from the University of Bordeaux, “To describe the myocardial infarction care pathway during the year following hospital discharge, and the use of and adherence to secondary prevention drugs. A cohort study was conducted using data from the main French health insurance reimbursement database of the ex-Aquitaine region. Information about the medical and pharmaceutical care of hospitalized patients in 2018 was collected for 12 months. Medication adherence was assessed by using the proportion of days covered by the treatment and persistence. A total of 3015 patients were included, and the mean age was 66 years. Almost 76% of the patients had a reimbursement for BAS (combined prescription of beta-blocker/antiplatelet/lipid-lowering drug), BASI (combined prescription of beta-blocker/antiplatelet/lipid-lowering drug/angiotensin-converting enzyme inhibitor) or AS (combined prescription of antiplatelet/lipid-lowering drug) treatment. Medication adherence was around 83% for aspirin and 75% for lipid-lowering drugs for the 1-year persistence. During the same time, the proportion of days covered was suboptimal. Almost 4% of patients died after leaving hospital, 45% went to a cardiac rehabilitation centre and 23% had at least one hospital readmission, whatever the reason. Patients had a mean number of 11 general practitioner consultations during the year. Almost 41% of patients did not have a consultation with a cardiologist, and 38.4% had at least two consultations. Rehabilitation and general practitioner consultations were associated with adherence. These new results provide clear information on the medical care environment of patients, and help us to improve care transition.”

According to the news editors, the research concluded: “Close collaboration between healthcare practitioners is very important in the early stages of outpatient follow-up.”

This research has been peer-reviewed.

For more information on this research see: One-year care pathway after acute myocardial infarction in 2018: Prescription, medical care and medication adherence, using a French health insurance reimbursement database. Archives of Cardiovascular Diseases, 2022. Archives of Cardiovascular Diseases can be contacted at: Elsevier Masson, Corp Off, 65 Camille Desmoulins CS50083 Issy-Les-Moulineaux, 92442 Paris, France. (Elsevier - www.elsevier.com; Archives of Cardiovascular Diseases - http://www.journals.elsevier.com/archives-of-cardiovascular-diseases/)

The news correspondents report that additional information may be obtained from Karin Martin-Latry, Inserm UMR 1034, Biology of Cardiovascular Diseases, University of Bordeaux, 1, avenue de Magellan, 33600 Pessac, France. Additional authors for this research include Philippe Latry, Veronique Moysan, Camille Berges, Pierre Coste, Herve Douard, Yann Pucheu, Nadine Agosti and Thierry Couffinhal.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1016/j.acvd.2021.12.003. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

The publisher’s contact information for the journal Archives of Cardiovascular Diseases is: Elsevier Masson, Corp Off, 65 Camille Desmoulins CS50083 Issy-Les-Moulineaux, 92442 Paris, France.

(Our reports deliver fact-based news of research and discoveries from around the world.)